Author

Jiehua Zhou

University of California San DiegoORCID 0000-0002-2088-1218Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jiehua Zhou1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

Alberto HerreraiD· 1 shared Andrea Zoey LiuiD· 1 shared Bernadette Anne Chua· 1 shared Carlo M. Ong· 1 shared Edward David Ball· 1 shared Eric J. BennettiD· 1 shared Evelyn L. TaniD· 1 shared Fanny ZhouiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alberto HerreraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBloodPeer-reviewedOct 20, 2025

The Proteostasis Network is a Therapeutic Target in Acute Myeloid Leukemia

Kentson Lam, Yoon Joon Kim, Evelyn L. Tan…·Robert A. J. Signer

This study shows that proteasome inhibitors are ineffective in AML due to activation of HSF1 and autophagy, and that combining autophagy and proteasome inhibition effectively kills AML cells.

9 citationstop 3%

humanproteomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintOct 28, 2023

Inhalation Delivered RNA Aptamer for Therapeutics against SARS-CoV2

Min-Sun Song, Jiehua Zhou, Alberto Herrera…·John J. Rossi

The paper explores the use of inhalation-delivered RNA aptamers as a therapeutic approach against SARS-CoV-2.

1 citation

𝕏 PostBluesky